Search - tctmd.com

Displaying 281 - 300 of 931

Sort: Relevancy | Date

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Daily News

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

L.A. McKeown

July 02, 2020

Podcast TCTMD Talking Points

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

July 01, 2020

News Conference News EuroPCR 2020

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Yael L. Maxwell

July 01, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

L.A. McKeown

June 29, 2020

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

June 26, 2020

Presentation TVT 2020

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

Presenter: Tsuyoshi Kaneko

June 21, 2020

Presentation TVT 2020

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Presenter: Tsuyoshi Kaneko

June 20, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Daily News

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

L.A. McKeown

June 17, 2020

Presentation

In-hospital Outcomes and Readmissions forValve-in-Valve TAVR vs Surgical Redo

June 01, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Recovered Paclitaxel PAD Data Shift the Mortality Picture

L.A. McKeown

May 14, 2020

News Opinion Fellow Talk

A Program for Every Fellow: Maximizing Your Conference Experience as a Trainee

Luai Tabaza, MD

March 11, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

Presentation JIM 2020

The use of Allegra-Valve (NVT) in the Valve-in-Valve setting

Presenter: Ulrich Schafer

February 13, 2020

Presentation JIM 2020

Low coronary ostia in ViV

Presenter: Antonio Mangieri

February 12, 2020

Advertisement

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

Intact Vascular Announces Positive One-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Newer TAVR Devices Reassure in Failed Surgical Valves

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

In-hospital Outcomes and Readmissions forValve-in-Valve TAVR vs Surgical Redo

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Recovered Paclitaxel PAD Data Shift the Mortality Picture

A Program for Every Fellow: Maximizing Your Conference Experience as a Trainee

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

The use of Allegra-Valve (NVT) in the Valve-in-Valve setting

Low coronary ostia in ViV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content